Drug intelligence / Profile preview

Xiaoangtiaojing Decoction

Development stage: Unknown
Lead developer: Henan Provincial Hospital of Traditional Chinese Medicine
Administration: Oral

Overview

Xiaoangtiaojing Decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed by the Henan Province Hospital of TCM for the treatment of polycystic ovary syndrome (PCOS). It is specifically indicated for patients presenting with the TCM syndrome type of Qi stagnation and dampness-stasis. The decoction is designed to improve endometrial receptivity and regulate metabolic and hormonal imbalances associated with PCOS. In clinical research, it is typically evaluated as an adjuvant therapy to be used in combination with standard hormonal treatments, such as Diane-35 (cyproterone acetate and ethinylestradiol), to enhance therapeutic outcomes compared to hormonal therapy alone.

Other names: Xiaoangtiaojing Decoction

Beyond the preview

Go deeper on Xiaoangtiaojing Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiaoangtiaojing Decoction.

Explore the full profile